Cipher Pharmaceuticals

Cipher Pharmaceuticals is a specialty pharmaceutical company focused on developing improved formulations of existing drugs. The company targets specific markets to in-license products that utilize currently marketed molecules combined with innovative drug delivery technologies to enhance performance. Cipher's expertise lies in identifying product opportunities and managing the associated clinical and regulatory development processes. Its product portfolio includes dermatology products, hospital acute care products, and specialty medicines, among others. The company operates primarily in Canada and the United States and generates revenue by out-licensing its products to partners, thereby creating royalty streams.